Suchergebnisse - "Tabarsi, Payam"

PubPharm (10)

1

Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults : An immuno-bridging clinical trial

enthalten in: International immunopharmacology | 2024

von Tabarsi, P. | Mamishi, S. | Anjidani, N. | +11

2

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine : a phase 3 randomized placebo-controlled trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

3

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination : A randomized placebo-controlled trial

enthalten in: Immunology | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +5

4

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine : a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

5

Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Salehi, M. | Hosseini, H. | Jamshidi, H. | +9

6

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran : findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

enthalten in: BMJ open | 2022

von Mohraz, M. | Salehi, M. | Tabarsi, P. | +13

ErratumIn: BMJ Open. 2022 Nov 7;12(11):e056872corr1. - PMID 36344009

7

SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran

enthalten in: Frontiers in public health | 2022

von Darvishian, M. | Sharafkhah, M. | Mohammadi, Z. | +17

8

Diagnosis of COVID-19 by Serology in Admitted Patients with Negative RT-PCR Assay

enthalten in: Iranian journal of allergy, asthma, and immunology | 2021

von Rezaei, M. | Baghaei, P. | Sadr, M. | +7

9

SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran : a population-based cross-sectional study

enthalten in: The Lancet. Infectious diseases | 2021

von Poustchi, H. | Darvishian, M. | Mohammadi, Z. | +39

CommentIn: Lancet Infect Dis. 2021 May;21(5):604-605. - PMID 33600756

10

Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran

enthalten in: Iranian journal of immunology : IJI | 2021

von Mortezagholi, S. | Rostamzadeh, D. | Alinejad, M. | +3

1
[1]